Vitamin B12 Injection

This product is an anti-anemia drug. Vitamin B12 participates in methyl conversion and folic acid metabolism in the body, and promotes the conversion of 5-methyltetrahydrofolate into tetrahydrofolate. When it is deficient, it leads to DNA synthesis disorders and affects the maturation of red blood cells. This product also promotes the conversion of methylmalonic acid into succinic acid and participates in the tricarboxylic acid cycle. This effect is related to the synthesis of nerve myelin lipids and the maintenance of the integrity of myelinated nerve fiber function. The nerve damage caused by vitamin B12 deficiency may be related to this.

The main ingredient of this product is vitamin B12.

Multivitamins are mainly used for megaloblastic anemia caused by intrinsic factor deficiency, and can also be used as an adjuvant treatment for subacute combined degenerative nervous system diseases such as neuritis.

Intramuscular injection, adults, 0.025-0.1 mg per day or 0.05-0.2 mg every other day. When used for neuritis, the dosage can be increased as appropriate. For children, intramuscular injection of 25-100 ug/time, once a day or every other day. Avoid repeated administration to the same site, and be especially careful with newborns, premature infants, infants, and young children.

Intramuscular injection may occasionally cause rash, itching, diarrhea and allergic asthma, but the incidence is low, and anaphylactic shock may occur in very rare cases.

Not yet clear.

Aminosalicylic acid may weaken the effect of this product.

Too high a temperature or too long a disinfection time may cause it to decompose, so it should be kept in a sealed container away from light.

1ml:1mg

Fuzhou FU Yao Pharmaceutical Co., Ltd.

• Founded in:

  2001-06-07

• Address:

  No. 279, Zhongxia, Gushan Town, Jin'an District, Fuzhou City

• Tax NO.:

  91350100727934373D

• Registered Funds:

  30 million yuan

• Website:

  Log in to view

• Email:

  Log in to view